Idrees Sobia, Ashfaq Usman A
Department of Bioinformatics and Biotechnology, Government College University (GCU), Faisalabad, Pakistan.
Asian Pac J Trop Biomed. 2013 Mar;3(3):232-6. doi: 10.1016/S2221-1691(13)60057-X.
Dengue virus infection has become a global threat affecting around 100 countries in the world. Currently, there is no licensed antiviral agent available against dengue. Thus, there is a strong need to develop therapeutic strategies that can tackle this life threatening disease. RNA interference is an important and effective gene silencing process which degrades targeted RNA by a sequence specific process. Several studies have been conducted during the last decade to evaluate the efficiency of siRNA in inhibiting dengue virus replication. This review summarizes siRNAs as a therapeutic approach against dengue virus serotypes and concludes that siRNAs against virus and host genes can be next generation treatment of dengue virus infection.
登革病毒感染已成为一种全球威胁,影响着世界上约100个国家。目前,尚无针对登革热的获批抗病毒药物。因此,迫切需要开发能够应对这种危及生命疾病的治疗策略。RNA干扰是一种重要且有效的基因沉默过程,它通过序列特异性过程降解靶向RNA。在过去十年中,已经进行了多项研究来评估小干扰RNA(siRNA)抑制登革病毒复制的效率。本综述总结了将siRNA作为针对登革病毒血清型的治疗方法,并得出结论,针对病毒和宿主基因的siRNA可能成为登革病毒感染的下一代治疗方法。